Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7422 p439
14 October 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Dedicated pharmacy budgets needed in primary care, says IPF

Primary care trusts must have dedicated pharmacy budgets if community pharmacists are to be able to develop their roles, the Independent Pharmacy Federation believes.

In its response to the All-Party Pharmacy Group’s inquiry into the future of pharmacy (PJ, 24 June, p739), the IPF says that one of the main barriers to progress in the development of pharmacy services is the false expectation that GP commissioning will cascade sustainable funds and development to community pharmacy.

“A dedicated budget should be allocated to pharmacy to avoid a wrangle with the medical profession and PCTs charged with the responsibility to implement extended medicines management,” it says. The PCT should commission enhanced services from a “national menu” and purchase services assessed to be required as a result of a robust local pharmaceutical care needs assessment. Ring-fencing of funds could even be taken to higher organisational levels, the IPF goes on to suggest.

“We have not observed PCT willingness to support pharmacy innovation; there is concentration on keeping within the allocated budget and practice-based commissioning will take priority. Opportunities would be greater if budgets were consolidated regionally or nationally because funds could be allocated to specific developmental projects on a consistent basis for pharmacy input.

“There would be less post-coding of services and better public recognition of what should be available if there was a better roll out of national templates. … We suggest the creation of a new directorate of integrated care at strategic health authority level to oversee PCT operational effort in structuring collaboration between medical and pharmaceutical effort, together with other health care professionals as required,” the IPF adds.

In addition, the IPF suggests that the new community pharmacy contract in England may have curbed, rather than augmented, the development of relationships between community pharmacists and GPs.

“It could be argued that the pharmacy contract has retarded the development of relationships,” the IPF says. “Increased paperwork is not well received by doctors, which influences their perception of added value. Practice-based commissioning and the loss of community pharmacists on professional executive committee have increased tribalism,” it adds.

Back to Top


©The Pharmaceutical Journal